CompletedPhase 3NCT00662714
Early Diagnosis of Diabetes Mellitus in Patients With Cystic Fibrosis
Studying Neonatal diabetes mellitus
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Mukoviszidose Institut gGmbH
- Principal Investigator
- Manfred Ballmann, Prof. Dr.St. Josef Hospital,Alexandrinenstrasse 5,44791 Bochum, Germany
- Intervention
- Repaglinide(drug)
- Enrollment
- 73 enrolled
- Eligibility
- 10 years · All sexes
- Timeline
- 2001 – 2011
Study locations (30)
- Universitätsklinik für Kinder- und Jugendheilkunde, Graz, Austria
- Universitätsklinik für Kinder- und Jugendheilkunde, Vienna, Austria
- CRCM adultes, Lille, France
- CRCM adultes, Centre Hospitalier Lyon Sud, Lyon, France
- APHP, CRCM pediatrique, Hopital Necker, Paris, France
- APHP, CRCM pediatrique, Hopital Robert Debre, Paris, France
- APHP, CRCM pediatrique, Hopital Cochin, Paris, France
- CRCM adultes, Hopital Civil, Strasbourg, France
- Helios Klinikum Emil von Behring, Berlin, Germany
- Heliosklinikum Berlin-Buch, Berlin, Germany
- Prof.-Hess-Kinderklinik/ Zentralkrankenhaus, Bremen, Germany
- Zentralkrankenhaus "Links der Weser", Bremen, Germany
- Klinik und Poliklinik für allgemeine Kinderheilkunde, Cologne, Germany
- Universitätskinderklinik Düsseldorf, Düsseldorf, Germany
- Klinik für Kinder und Jugendliche Erlangen, Erlangen, Germany
- +15 more locations on ClinicalTrials.gov
Collaborators
Novo Nordisk A/S · Mucoviscidose-ABCF2 · Assistance Publique - Hôpitaux de Paris
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00662714 on ClinicalTrials.govOther trials for Neonatal diabetes mellitus
Additional recruiting or active studies for the same condition.